Ad 7.052332
vance 3.2094193
ments 2.594875
Ġin 0.14381307
Ġthe 2.668888
Ġtreatment 3.8444786
Ġof 0.100817285
Ġmelan 5.2803516
oma 0.04012893
Ġhave 1.119363
Ġgreatly 4.41804
Ġimproved 0.59347683
Ġthe 0.71506584
Ġpotential 6.3794117
Ġfor 0.24079917
Ġlong 1.4174285
- 0.10803005
term 0.005352592
Ġremission 5.337792
, 1.9776425
Ġparticularly 4.4460707
Ġwith 2.3980663
Ġthe 1.04229
Ġuse 0.99199295
Ġof 0.003281215
Ġimmune 3.123946
Ġcheckpoint 0.6955846
Ġinhibitors 0.27524197
Ġand 3.7320528
Ġadj 4.760416
u 0.11149161
vant 0.00031775475
Ġtherapies 1.6298859
. 0.42206255
ĠThese 3.809122
Ġtreatments 1.9161732
Ġhave 1.2987223
Ġshown 4.4943147
Ġpromising 2.325707
Ġresults 0.42765582
Ġin 0.83813936
Ġimproving 4.214895
Ġsurvival 1.1487156
Ġrates 1.3002759
Ġfor 1.8508939
Ġpatients 0.44513705
Ġat 4.8294096
Ġdifferent 5.0407248
Ġstages 0.23018377
Ġof 0.10816008
Ġmelan 1.483029
oma 0.0023966692
. 0.70430607
ĠBy 6.466262
Ġexploring 5.675523
Ġthe 0.6665517
Ġcase 7.564026
Ġof 0.5143585
ĠMr 4.380752
. 0.19179492
ĠB 2.706776
, 0.41476032
Ġwe 1.4191182
Ġcan 1.2029784
Ġdelve 6.441835
Ġinto 0.39604178
Ġthe 0.4206072
Ġimplications 5.6025906
Ġof 0.20421961
Ġthese 1.2336888
Ġtreatments 1.2163616
Ġand 1.1490746
Ġdiscuss 4.182941
Ġthe 1.0963652
Ġevidence 5.7865334
Ġsupporting 2.1011677
Ġtheir 0.6476089
Ġefficacy 3.0474434
. 0.23361406
Ċ 0.3905351
Mel 15.516775
an 0.0042379485
oma 0.02715466
Ġis 0.74880934
Ġa 0.97807175
Ġtype 1.7566688
Ġof 0.0013229182
Ġskin 0.3618314
Ġcancer 0.0096382545
Ġthat 0.46755302
Ġarises 2.4498646
Ġfrom 0.1695902
Ġthe 1.5341343
Ġpigment 0.64136297
- 0.31916887
producing 0.09094743
Ġcells 0.35547397
, 2.404053
Ġknown 1.2613962
Ġas 0.0019299096
Ġmelan 0.003611668
ocytes 0.0008514707
. 0.32350555
ĠIt 1.9796346
Ġis 0.6638345
Ġnotorious 8.073021
Ġfor 0.045082293
Ġits 0.43077257
Ġaggressive 2.6698327
Ġnature 1.0580139
Ġand 0.8026375
Ġpotential 5.6316504
Ġto 0.7303862
Ġmetast 0.951284
as 0.0024934665
ize 0.008302632
. 1.6503121
ĠHowever 4.1863117
, 0.011401097
Ġwith 2.6687577
Ġthe 1.588062
Ġadvent 1.6853892
Ġof 0.013098506
Ġimmune 1.9844103
Ġcheckpoint 0.10282852
Ġinhibitors 0.24358848
, 0.5853765
Ġsuch 3.040624
Ġas 0.008408476
Ġp 2.078411
emb 0.0015127894
rol 0.004695549
iz 0.00045346864
um 0.0037831923
ab 0.00028031383
Ġand 0.97237587
Ġn 0.3532433
iv 0.00043402638
ol 0.0001810496
um 0.008741527
ab 0.00063965475
, 0.078348294
Ġremarkable 7.8810225
Ġadvancements 3.5857239
Ġhave 0.25573045
Ġbeen 0.071693055
Ġmade 0.0669096
Ġin 0.22126715
Ġthe 0.4492312
Ġtreatment 0.17914465
Ġof 0.064565055
Ġadvanced 2.1477723
Ġmelan 0.5100286
oma 0.019942254
. 0.18776073
Ċ 1.4900382
Imm 4.784077
une 0.025471713
Ġcheckpoint 0.1498335
Ġinhibitors 0.0969077
Ġwork 1.3968128
Ġby 0.078410886
Ġenhancing 4.359998
Ġthe 0.2873062
Ġbody 1.0685754
's 0.01509465
Ġimmune 1.1871221
Ġresponse 0.495631
Ġagainst 1.7740443
Ġcancer 0.7945755
Ġcells 0.76284754
. 0.44279772
ĠThey 1.7160796
Ġinhibit 3.4533024
Ġthe 1.0919902
Ġactivity 2.229608
Ġof 0.0061764154
Ġproteins 2.5588148
Ġcalled 1.8867801
Ġimmune 2.0869155
Ġcheckpoints 0.13918054
, 0.5101957
Ġwhich 0.22780515
Ġrestrict 6.4091306
Ġthe 0.39323002
Ġimmune 1.5378841
Ġsystem 0.25461543
's 1.1796144
Ġability 0.3589129
Ġto 0.0019683088
Ġrecognize 1.8667504
Ġand 0.35765344
Ġtarget 3.453889
Ġcancer 0.32779595
Ġcells 0.14421865
. 0.14917801
ĠBy 2.2504394
Ġblocking 1.6546876
Ġthese 0.55315393
Ġcheckpoints 1.3633987
, 0.03334884
Ġthe 0.9544401
Ġimmune 0.44059122
Ġsystem 0.06004513
Ġis 0.42572
Ġunleashed 3.8209138
Ġto 0.66473716
Ġattack 1.2129622
Ġand 2.3547246
Ġdestroy 0.6289393
Ġthe 1.320865
Ġtumor 1.7864803
Ġcells 1.5511822
. 0.17581576
Ċ 0.9996237
In 2.4772902
Ġthe 1.3378906
Ġcase 0.19422373
Ġof 0.06233773
ĠMr 0.1355682
. 0.0042368714
ĠB 0.004033974
, 0.042550642
Ġa 2.607279
Ġ55 4.020839
- 0.2155526
year 0.002670175
- 0.12058508
old 0.00094507297
Ġmelan 6.8622355
oma 9.425254e-05
Ġpatient 0.08355319
Ġdiagnosed 4.1669884
Ġwith 0.2823677
Ġstage 1.176805
ĠIV 0.48782742
Ġmetast 2.254156
atic 0.008969436
Ġmelan 0.98857224
oma 0.00054196373
, 0.39106745
Ġtreatment 1.8496419
Ġwith 0.15487616
Ġa 3.3893487
Ġcombination 0.9767444
Ġof 0.038797107
Ġimmune 1.3124326
Ġcheckpoint 0.004016438
Ġinhibitors 0.06613997
Ġled 2.3979168
Ġto 0.0054255817
Ġa 0.6897199
Ġsignificant 3.5112727
Ġimprovement 0.7121309
Ġin 0.05736996
Ġhis 0.56134427
Ġprog 2.800928
nosis 0.0015057466
. 0.16005017
ĠStudies 7.934736
Ġhave 0.39148524
Ġshown 0.3318777
Ġthat 0.16251934
Ġthe 1.2903181
Ġuse 1.6352087
Ġof 0.004681837
Ġp 2.967738
emb 0.0016189339
rol 0.0032915017
iz 0.0006692382
um 0.0012960006
ab 3.2855354e-05
Ġand 1.3885065
Ġn 0.12092277
iv 9.9616926e-05
ol 0.00012977766
um 0.0015621595
ab 7.922942e-05
Ġin 0.73197937
Ġpatients 2.307651
Ġwith 0.10311427
Ġadvanced 0.87838024
Ġmelan 0.108030245
oma 0.0019679493
Ġcan 1.335635
Ġresult 1.8294114
Ġin 0.0019148
Ġdurable 3.5448306
Ġresponses 0.4765741
Ġand 1.2224579
Ġlong 2.24693
- 0.050273668
term 0.062165633
Ġremission 3.1152165
. 0.46842232
ĠIn 2.3712177
Ġa 1.985962
Ġstudy 1.3111129
Ġby 1.855076
ĠRobert 4.6567826
Ġet 4.229309
Ġal 0.013877184
., 1.0596652
Ġthe 1.7556673
Ġoverall 2.6384056
Ġresponse 0.31672457
Ġrate 0.05227211
Ġto 1.4697084
Ġp 1.1787307
emb 0.00048227116
rol 0.0023306492
iz 0.00033319838
um 0.0008808795
ab 5.216904e-05
Ġwas 0.7303914
Ġ33 4.428897
%, 1.2070103
Ġwith 0.52757496
Ġa 1.0892223
Ġmedian 1.1648835
Ġoverall 2.935199
Ġsurvival 0.14649495
Ġof 0.37458926
Ġ23 4.3874445
Ġmonths 0.9870632
, 2.7851138
Ġproviding 5.752478
Ġhope 2.2145557
Ġfor 0.36462238
Ġpatients 1.0362628
Ġlike 2.8353977
ĠMr 0.0053601433
. 0.003307466
ĠB 0.0021862614
. 0.24946134
Ċ 0.49538758
Ad 4.775305
ju 0.019941524
vant 0.0028080614
Ġtherapies 0.9525595
, 1.8012582
Ġwhich 1.7690166
Ġare 0.2747826
Ġadministered 1.8463657
Ġalongside 2.9523382
Ġprimary 1.2273338
Ġtreatments 0.8619739
, 0.2599035
Ġhave 1.2352118
Ġalso 0.17499119
Ġplayed 4.0220137
Ġa 0.3775151
Ġcrucial 2.3914192
Ġrole 0.01410385
Ġin 0.0054345117
Ġimproving 0.9818473
Ġsurvival 1.3887835
Ġrates 0.19978866
Ġin 1.8334906
Ġpatients 0.7797818
Ġwith 0.12006636
Ġmelan 0.58143425
oma 0.0013838573
. 0.030851854
ĠIn 1.7374839
Ġparticular 3.0101793
, 0.0016049029
Ġtargeted 3.4496129
Ġtherapies 0.4382154
Ġand 3.1286154
Ġcombination 5.84158
Ġtherapies 1.4873023
Ġhave 0.4839699
Ġshown 1.2444106
Ġpromising 1.1263485
Ġoutcomes 4.3513227
. 0.91968924
ĠTarget 2.4535959
ed 0.0009855822
Ġtherapies 0.11426961
, 1.3036048
Ġsuch 0.41007268
Ġas 0.0007681936
ĠBRA 1.773904
F 0.012538297
Ġand 1.5274321
ĠME 0.016151618
K 0.0006407295
Ġinhibitors 0.04371563
, 0.033393275
Ġspecifically 3.7444756
Ġtarget 0.16581334
Ġthe 1.0045385
Ġgenetic 2.3243158
Ġmutations 0.28701484
Ġpresent 2.2269268
Ġin 0.048226535
Ġmelan 0.49757278
oma 0.119890764
Ġcells 0.59032476
. 0.6570368
ĠThese 2.2432227
Ġinhibitors 2.7560077
Ġhave 1.4099066
Ġbeen 0.74301386
Ġsuccessful 3.9520097
Ġin 0.09618468
Ġpatients 3.402317
Ġwith 0.42936233
ĠBRA 0.3348321
F 0.00010450542
Ġgene 5.670436
Ġmutations 0.049776055
, 0.5889818
Ġincluding 5.2260523
ĠMr 0.94990325
. 0.002880329
ĠB 0.011178415
, 1.3076308
Ġleading 3.6431577
Ġto 0.009701087
Ġhigher 5.4507565
Ġresponse 0.57371485
Ġrates 0.047426824
Ġand 0.34690762
Ġlonger 0.72195035
Ġprogression 1.3898739
- 0.054228276
free 0.0006382224
Ġsurvival 0.10419632
. 0.83563364
Ċ 1.2045103
Furthermore 4.1471453
, 0.00037791664
Ġcombination 0.3944482
Ġtherapies 0.21312289
Ġthat 3.1395335
Ġcombine 1.0920513
Ġimmune 2.5029397
Ġcheckpoint 0.009464223
Ġinhibitors 0.049857065
Ġwith 0.47666788
Ġtargeted 0.18674329
Ġtherapies 0.20391522
Ġhave 0.426539
Ġshown 1.2203574
Ġeven 2.3291183
Ġmore 1.0765935
Ġimpressive 2.4484868
Ġresults 0.2521872
. 0.26922208
ĠFor 2.7166727
Ġinstance 1.6393471
, 0.0010807512
Ġthe 1.7504526
Ġcombination 0.45878023
Ġof 0.016469445
Ġdab 3.075825
raf 0.00018402888
en 0.0012869284
ib 8.948419e-05
Ġand 0.7862934
Ġtram 0.10791
et 0.00022457016
in 0.00076783594
ib 0.00016018527
, 1.3163676
ĠBRA 1.6555309
F 0.0001902296
Ġand 0.3630356
ĠME 0.005201234
K 7.648668e-05
Ġinhibitors 0.029277949
Ġrespectively 1.2152008
, 0.0010060486
Ġwith 4.981478
Ġimmun 4.881678
otherapy 0.1097535
Ġhas 1.3434242
Ġdemonstrated 3.0106285
Ġsignificant 3.2321894
Ġimprovements 1.6964587
Ġin 0.08643109
Ġoverall 1.3760377
Ġresponse 1.0758286
Ġrates 0.65739167
Ġand 0.6011474
Ġprogression 0.6716515
- 0.019146325
free 0.0005024268
Ġsurvival 0.027918125
. 0.6769432
ĠThis 2.7045887
Ġcombination 1.5073034
Ġtherapy 1.3948643
Ġhas 1.0410787
Ġbeen 1.1771932
Ġapproved 2.5843894
Ġby 0.6966802
Ġthe 0.01766162
ĠFDA 0.25068513
Ġfor 0.58041155
Ġthe 0.75464225
Ġtreatment 0.042648356
Ġof 0.0032580115
Ġmelan 1.6070331
oma 0.015197522
Ġpatients 1.6826025
Ġwith 0.30068716
ĠBRA 0.11133676
F 0.003515603
Ġmutations 2.2454553
. 0.41678813
Ċ 0.4181164
Overall 3.5429728
, 0.0023215115
Ġadvancements 3.8322155
Ġin 0.018838577
Ġmelan 2.036727
oma 9.925743e-05
Ġtreatment 0.18793564
, 3.5975893
Ġparticularly 1.5160621
Ġthe 1.0436108
Ġuse 0.27362847
Ġof 0.0038138248
Ġimmune 0.14890902
Ġcheckpoint 0.00424579
Ġinhibitors 0.0092584
Ġand 0.26098
Ġadj 0.42350802
u 0.007073248
vant 2.0815281e-05
Ġtherapies 0.053167965
, 0.035763297
Ġhave 0.123594224
Ġsignificantly 2.389362
Ġincreased 2.9909334
Ġthe 0.42384773
Ġpotential 1.3878764
Ġfor 0.034717128
Ġlong 0.19358161
- 0.010843343
term 0.0029597152
Ġremission 0.30684942
Ġand 1.5896276
Ġimproved 0.98165256
Ġsurvival 0.54302603
Ġrates 0.12660095
. 1.2937478
ĠThese 2.2091901
Ġtreatments 0.6711823
Ġhave 0.5985023
Ġshown 2.2765012
Ġpromising 1.3612871
Ġresults 0.11391498
Ġin 0.5471671
Ġpatients 0.92406034
Ġat 1.589661
Ġdifferent 0.3530201
Ġstages 0.012783256
Ġof 0.041864485
Ġmelan 0.28544372
oma 0.00028889967
, 0.46210656
Ġboth 6.7332125
Ġin 1.4210922
Ġterms 0.81482476
Ġof 0.00058687344
Ġimproved 4.0954423
Ġoverall 2.5754836
Ġresponse 0.8334637
Ġrates 0.27946994
Ġand 0.09784366
Ġincreased 1.9832177
Ġoverall 2.3342857
Ġsurvival 0.05674832
. 0.2635843
ĠThe 2.9994113
Ġcase 1.8507184
Ġof 0.026649514
ĠMr 0.009694105
. 0.00047505385
ĠB 0.0018538273
Ġexempl 3.0835147
ifies 0.010786769
Ġthe 0.5616584
Ġefficacy 2.996157
Ġof 0.029808797
Ġthese 0.805024
Ġtreatments 0.27512816
, 1.0323285
Ġwith 3.3479798
Ġhis 1.8913064
Ġfavorable 5.8508515
Ġresponse 0.18348052
Ġto 0.13131994
Ġimmune 1.6668336
Ġcheckpoint 0.0019004669
Ġinhibitors 0.08089844
Ġand 0.31200746
Ġtargeted 3.0189815
Ġtherapies 0.2480863
. 0.82729334
ĠContinued 5.814752
Ġresearch 0.43078157
Ġand 1.5995895
Ġadvancements 3.36799
Ġin 0.18951188
Ġthis 3.7689533
Ġfield 0.27000389
Ġoffer 5.471599
Ġhope 1.0047138
Ġfor 0.21638352
Ġmelan 3.4945438
oma 0.00034392995
Ġpatients 0.009237345
, 1.845767
Ġas 2.1017847
Ġthese 2.524987
Ġtreatments 0.43440405
Ġpave 4.039992
Ġthe 0.019621374
Ġway 0.03115452
Ġfor 0.16562854
Ġbetter 3.0764296
Ġoutcomes 1.0119385
Ġand 1.4683126
Ġpotentially 3.803446
Ġhigher 8.959145
Ġcure 0.7852039
Ġrates 0.00186613
. 0.57156426
